Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001415889-25-014415

Director bought 5,040 shares at an average $13.66 ($68,821)

From the SEC's structured data for this filing

Trades in this filing

Heron Patrick J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-21 Purchase : show line 1 in the form +2,520 $13.66 $34,423 20,014 I
2025-05-22 Purchase : show line 2 in the form +2,520 $13.65 $34,398 22,534 I
Open-market purchases · 5,040 sh · avg $13.66 · $68,821
Loading xslF345X05/form4-05232025_080546.xml…